Paragen Bio
Advanced technology for halting autoimmune diseases's impact on healthy tissues and organs, empowering doctors to preserve and protect patient health
est. 2018
SanegeneBio
Sanegene Bio is committed to advancing transformative RNAi therapies that address global unmet medical needs.
28 employees · est. 2021 · Woburn, United States
Paragen Bio is the older company (2018 vs 2021).
Side-by-Side Comparison
| Metric | Paragen Bio | SanegeneBio |
|---|---|---|
| Founded | ||
| Founded | 2018 older | 2021 |
| Headquarters | ||
| Headquarters | Not tracked yet | Woburn, United States |
| Employees | ||
| Employees | Not tracked yet | 28 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Life Sciences | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Series Unknown | Series B |
| Total Funding | ||
| Total Funding | $6.00M | $190.00M |
| Funding Rounds | ||
| Funding Rounds | 1 | 2 |
| Services | ||
| Services | Not tracked yet | Drug Discovery and Development, Therapeutic Pipeline Management, RNAi Medicines, Targeted Delivery Platform |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Metabolic Disorders, Individuals with Autoimmune Diseases, Healthcare Providers treating Cardiovascular Diseases, Biotech and Pharmaceutical Partners |
| Taxonomy | ||
| Taxonomy | Autoimmune Diseases, Technology, Immune System, Tissue Preservation, Organ Protection, Medical Innovation, Disease Management | RNAi Therapies, Genetic Medicines, Obesity Treatment, Cardiometabolic Diseases, Autoimmune Diseases, Drug Discovery, LEAD Technology, Tissue-specific Gene Silencing, Subcutaneous Dosing, RNA Interference, Metabolic Diseases, Cardiovascular Diseases, Immunology |
| Website | ||
| Website | paragenbio.com | sanegenebio.com |
About Paragen Bio
Paragen Bio is a biopharmaceutical startup with a mission to combat the impact of autoimmune diseases on healthy tissues and organs. Founded in 2018, the company has attracted notable attention from investors, securing a significant $6.00M in its last venture round investment on 14 August 2018. This...
About SanegeneBio
Sanegene Bio, a clinical-stage biotechnology company, is committed to advancing transformative RNAi therapies that address global unmet medical needs. Founded in 2021 by industry veterans with deep expertise in RNA interference, Sanegene Bio leverages its proprietary LEAD™ platform to enable tissue-...
We will tell you when either one moves
BounceWatch watches Paragen Bio and SanegeneBio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Paragen Bio and SanegeneBio — by email.
Frequently Asked Questions
Compare Paragen Bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Paragen Bio on 12 Sep 2024, and SanegeneBio on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
